Pharmaceutical Commerce - October 2025

Pharmaceutical Commerce: October 2025 Interactive Digital Edition

October 08, 2025

20

5

View the Pharmaceutical Commerce October 2025 issue in an interactive format.

Staying Current on Cold Chain

October 08, 2025

20

5

Explore the latest innovative strategies and insider perspectives on cold chain management and sustainable packaging in the October issue of Pharmaceutical Commerce.

Surveying the Industry

October 08, 2025

20

5

Introducing our deep dive into the state of biopharma at the moment—directly from the voices of those decision-makers most impacted by the current industry volatility.

Empowering Patients as Partners: The Next Frontier for Pharma Companies

October 08, 2025

20

5

Life sciences organizations have an opportunity to move beyond patient-centered care and embrace a model that values lived experience, fosters collaboration, and positions patients as active contributors to research, treatment, and innovation.

Why Your EHR Messaging Must Be Real-Time

October 08, 2025

20

5

This first-party approach to data-driven messaging can ensure timely, compliant, and personalized engagement with healthcare providers at the point of care.

Bridging People, Process, and Technology

October 07, 2025

20

5

How can 360° connectivity drive pharma innovation?

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead

October 07, 2025

20

5

Advice for pharma distributors and dispensers on what they should do now in order to solidify a secure supply chain.

Building Resilient, Sustainable Pharma Supply Chains

October 06, 2025

20

5

Cencora executive Heather Zenk discusses how innovations in cold chain, data visibility, and sustainability strategies are transforming the drug delivery process.

Greener, Smarter, and Less Expensive: How Pharma Packaging is Evolving

October 06, 2025

20

5

As the sentiment of surveyed dangerous goods experts backs up, updated packaging pursuits can boost efficiency and cut costs—while mitigating the environmental impact.

Hubs as Revenue Protection: Rethinking Patient Access in the Era of Disruption

October 03, 2025

20

5

Amid intensified competition—and evolving IRA and PBM dynamics—leaders in the access space must now adopt a strategist mindset.

To Be or Not to Be Material? That is the Question

October 03, 2025

20

5

Companies must assess illicit trade risks under a new EU directive, making materiality and compliance critical for sustainability reporting.

Alternative Funding Programs Threaten Patient Access

October 02, 2025

20

5

Marketed as cost-saving tools, AFPs can also strain safety-net resources.

Popping the Gross-to-Net Bubble, Part VI: The Future of Pharmaceutical Pricing

October 02, 2025

20

5

From patent cliffs and government price controls, to self-pay models and staff-model HMOs, a look at the forces that could deflate the bubble—and those factors likely to keep it afloat a while longer.

Inside the MFN Pricing Actions

October 02, 2025

20

5

Amid pressures on pharma to match the lowest international prices, experts warn of “policy laundering” and discriminatory impact.

Pharma Commerce's 2025 State of the Industry Survey

September 26, 2025

20

5

Capturing insights from executives and industry experts on the biggest challenges shaping pharma today, from drug pricing pressures and access barriers to supply chain shifts, digital adoption, and evolving patient-centered care strategies.

Beyond the Brand Team: Why Every Employee Needs to Be Part of the Journey

July 10, 2025

20

5

Engaging the full workforce—from HR to R&D—can elevate launch outcomes, build trust, and create long-term brand ambassadors.